| Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline. (2006) | |||||||||
Abstract | |||||||||
| This author produced version paper published Neurobiology Disease This paper has been peer reviewed but does not include the final publisher proof corrections journal pagination Citation for the published paper Mansson Roland and Hansson Magnus and Morota Saori and Uchino Hiroyuki and Ekdahl Christine and Elm Eskil evaluation mitochondrial permeability transition primary neuroprotective target minocycline Neurobiology Disease Issue Oct http doi org nbd Access the published version may require journal subscription Published with permission from Elsevier nsson Re evaluation mitochondrial permeability transition primary neuroprotective target minocycline Roland nsson Magnus Hansson Saori Morota Hiroyuki Uchino Christine Ekdahl and Eskil Elm b Laboratory for Experimental Brain Research Department Clinical Sciences Lund University Sweden Department Neurology Malm University Hospital Malm Sweden Section Restorative Neurology Department Clinical Sciences Lund University Sweden Laboratory Cellular Neurobiology School Life Science Tokyo University Pharmacy and Life Science Hachioji Japan Department Anesthesiology Tokyo Medical University Hachioji Medical Center Tatemachi Hachioji Japan Address correspondence Roland nsson Laboratory for Experimental Brain Research Wallenberg Neuroscience Center BMC Lund Sweden Tel Fax mail roland mansson med Abstract Minocycline has been shown neuroprotective ischemic and neurodegenerative disease models and could potentially relevant for clinical use | |||||||||
Publication details | |||||||||
| |||||||||